Intuitive Surgical, Inc. (ISRG) Stock Price: $426.61+8.00 (+1.91%)
The total return cagr for Intuitive Surgical, Inc. (ISRG) stock is -18.93% over the past 12 months. The 3 year average growth rate is 10.90% and the 5 year cagr is 8.78%. Total return includes dividends reinvested.
The closing share price for Intuitive Surgical, Inc. (ISRG) stock was $426.61 for Tuesday, June 9, 2026, up +1.91% from the previous day.
ISRG Price Chart
ISRG Key Metrics
See All MetricsISRG Earnings Preview
Next Earnings Date
Jul 21, 2026
42 days away
EPS Estimate
2.50
Revenue Est.
$2.82B
Last Quarter Results
EPS
$2.50
vs Estimate
$2.11
Revenue
$2.77B
vs Estimate
$2.62B
ISRG Analyst Ratings
Consensus Rating
Based on 29 analysts
Average Price Target
$565.25
+32.5% upside
Low
$366.00
Current
$426.61
High
$750.00
ISRG Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $2.74 | N/A | 10 |
| Q2 2027 | N/A | $2.89 | N/A | 7 |
| Q3 2027 | N/A | $2.98 | N/A | 7 |
| Q4 2027 | N/A | $3.25 | N/A | 14 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $11.78 | N/A | 18 |
| FY 2028 | N/A | $13.31 | N/A | 10 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $3.12B | N/A | 10 |
| Q2 2027 | N/A | $3.24B | N/A | 7 |
| Q3 2027 | N/A | $3.31B | N/A | 7 |
| Q4 2027 | N/A | $3.63B | N/A | 14 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $13.27B | N/A | 18 |
| FY 2028 | N/A | $15.08B | N/A | 10 |
Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.
ISRG Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| 1ISRG | $151.09B | $426.61 | +1.91% | -18.93% | +8.78% | +19.47% |
ISRG Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- David J. Rosa